{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-001911","form_type":"8-K","ticker":"KALA","cik":"0001479419","company_name":"KALA BIO, Inc.","filed_at":"2026-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.170346+00:00","generated_at":"2026-05-15T21:38:26.902714+00:00","sec_items":["1.01","3.02","7.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"confidence":"high","headline":"KALA BIO launches AI infrastructure platform; licenses Researgency from Younet AI","bullets":["Exclusive worldwide license to Researgency platform for biotech field; initial 12-month term with renewal options.","Consideration includes up to $530k cash and issuance of 5 million shares of KALA common stock per term.","Company holds an irrevocable option to acquire Younet AI for $55 million, exercisable during the term.","Strategic pivot: KALA will deploy on-premises, data-sovereign AI for biotech clients targeting recurring revenue.","KALA will first deploy on its own MSC-S and KPI-012 data; preliminary findings expected in 12 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-001911","json":"https://secwatch.observer/filing/0001829126-26-001911.json","markdown":"https://secwatch.observer/filing/0001829126-26-001911.md","text":"https://secwatch.observer/filing/0001829126-26-001911.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626001911/0001829126-26-001911-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626001911/kalabio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:38:26.902714+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}